Peptidyl-glutamyl peptide-hydrolyzing activity: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
(No difference)
|
Latest revision as of 13:46, 6 September 2012
Peptidyl-glutamyl peptide-hydrolyzing (PGPH) enzyme activity is a means of proteolysis that cleaves peptide bonds in proteins immediately after acidic or branched-chain amino acids. One of the three catalytic β subunits of the proteasome has PGPH activity and is strongly inhibited by the proteasome inhibitor epoxomicin.[1]
References
- ↑ Meng L, Mohan R, Kwok BHB, Elofsson M, Sin N, Crews CM. (1999). Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci USA 96(18): 10403-10408.
External links
| Stub icon | This hydrolase article is a stub. You can help Wikipedia by expanding it. |
